^
BIOMARKER:
ALK positive
i
Other names: NBLST3, CD246, Anaplastic Lymphoma Kinase, Anaplastic Lymphoma Kinase (Ki-1), CD246 Antigen, Mutant Anaplastic Lymphoma Kinase, ALK, ALK Receptor Tyrosine Kinase, Anaplastic Lymphoma Receptor Tyrosine Kinase, ALK Tyrosine Kinase Receptor
Entrez ID:
ALK positive
NSCLC
brigatinib
Sensitive
:
A1
Expert Rev Anticancer Ther - 1wk
ALK positive
NSCLC
lorlatinib
Sensitive
:
A1
AACR 2021 - 3wk
ALK positive
NSCLC
alectinib
Sensitive
:
A1
ALK positive
NHL
crizotinib
Sensitive
:
A1
ALK positive
NSCLC
crizotinib
Sensitive
:
A1
ALK positive
NSCLC
bevacizumab + atezolizumab
Sensitive
:
A1
ALK positive
NSCLC
ceritinib
Sensitive
:
A1
ALK positive
NSCLC
atezolizumab
Sensitive
:
A1
ALK positive
Peripheral T-cell Lymphoma
crizotinib
Sensitive
:
A2
ALK positive
NSCLC
X-396
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
bevacizumab
Sensitive
:
B
ALK positive
NHL
brentuximab vedotin
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
atezolizumab
Sensitive
:
B
ALK positive
Lymphoma
crizotinib
Sensitive
:
B
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
crizotinib
Sensitive
:
B
ALK positive
Neuroblastoma
crizotinib
Sensitive
:
C1
ALK positive
NHL
alectinib
Sensitive
:
C1
ALK positive
T Cell Non-Hodgkin Lymphoma
ceritinib
Sensitive
:
C1
ALK positive
NSCLC
AUY922
Sensitive
:
C2
ALK positive
NSCLC
SAF-189
Sensitive
:
C2
ALK positive
NSCLC
TQ-B3139
Sensitive
:
C3
ALK positive
NSCLC
sintilimab
Sensitive
:
C3
ALK positive
NSCLC
PD-L1 inhibitor
Resistant
:
C3
ALK positive
LUAD
pemetrexed
Sensitive
:
C3
ALK positive
Solid Tumor
TQ-B3101
Sensitive
:
C3
ALK positive
Lung Non-Squamous Non-Small Cell Cancer
X-396
Sensitive
:
C3
VERI is free for non-commercial use, no login needed.
Content on this site is for research purposes only and is not intended  to be a substitute for medical advice.
For commercial access, including additional premium features, please contact us.
By using VERI, you are agreeing to our